Amikacin disulfateCAS# 39831-55-5 |
- Nutlin-3a chiral
Catalog No.:BCC1812
CAS No.:675576-98-4
- p53 and MDM2 proteins-interaction-inhibitor chiral
Catalog No.:BCC1830
CAS No.:939981-37-0
- p53 and MDM2 proteins-interaction-inhibitor racemic
Catalog No.:BCC1831
CAS No.:939983-14-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 39831-55-5 | SDF | Download SDF |
| PubChem ID | 38351 | Appearance | Powder |
| Formula | C22H47N5O21S2 | M.Wt | 781.76 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | BAY-416651 sulfate | ||
| Solubility | H2O : 100 mg/mL (127.92 mM; Need ultrasonic) DMSO : < 1 mg/mL (insoluble or slightly soluble) | ||
| Chemical Name | (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acid | ||
| SMILES | NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O.O[S](O)(=O)=O.O[S](O)(=O)=O | ||
| Standard InChIKey | FXKSEJFHKVNEFI-GCZBSULCSA-N | ||
| Standard InChI | InChI=1S/C22H43N5O13.2H2O4S/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21;2*1-5(2,3)4/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36);2*(H2,1,2,3,4)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+;;/m0../s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Amikacin sulfate(BAY416651 sulfate) is a semi-synthetic aminoglycoside antibiotic derived from kanamycin A.
Target: Antibacterial
Amikacin disrupts bacterial protein synthesis by binding to the 30S ribosome of susceptible organisms. Binding interferes with mRNA binding and tRNA acceptor sites leading to the production of non-functional or toxic peptides. Other mechanisms not fully understood may confer the bactericidal effects of amikacin. Amikacin is also nephrotoxic and ototoxic. Amikacin is useful against gentamicin-resistant gram-negative bacilli and also in the treatment of infections caused by susceptible Nocardia and nontuberculous mycobacteria.[1]. References: | |||||
Amikacin disulfate Dilution Calculator
Amikacin disulfate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.2792 mL | 6.3958 mL | 12.7916 mL | 25.5833 mL | 31.9791 mL |
| 5 mM | 0.2558 mL | 1.2792 mL | 2.5583 mL | 5.1167 mL | 6.3958 mL |
| 10 mM | 0.1279 mL | 0.6396 mL | 1.2792 mL | 2.5583 mL | 3.1979 mL |
| 50 mM | 0.0256 mL | 0.1279 mL | 0.2558 mL | 0.5117 mL | 0.6396 mL |
| 100 mM | 0.0128 mL | 0.064 mL | 0.1279 mL | 0.2558 mL | 0.3198 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Amikacin sulfate binds to 16S rRNA (bacterial 30S ribosome), causing misreading of mRNA and supressing proteins synthesis.
- H-Ala-OiPr.HCl
Catalog No.:BCC3193
CAS No.:39825-33-7
- Epitulipinolide diepoxide
Catalog No.:BCN5451
CAS No.:39815-40-2
- Taibaihenryiins A
Catalog No.:BCN3281
CAS No.:398129-59-4
- Penciclovir
Catalog No.:BCC4695
CAS No.:39809-25-1
- Azatadine dimaleate
Catalog No.:BCC4536
CAS No.:3978-86-7
- Boc-Tyr-OH
Catalog No.:BCC3458
CAS No.:3978-80-1
- 2-Amino-4-hydroxy-6-methylpyrimidine
Catalog No.:BCC8531
CAS No.:3977-29-5
- Bryonolol
Catalog No.:BCN2703
CAS No.:39765-50-9
- Dehydrovomifoliol
Catalog No.:BCN7562
CAS No.:39763-33-2
- 16,16-Dimethyl Prostaglandin E2
Catalog No.:BCC7843
CAS No.:39746-25-3
- H-Gln-OtBu.HCl
Catalog No.:BCC2918
CAS No.:39741-62-3
- SDZ 21009
Catalog No.:BCC7098
CAS No.:39731-05-0
- Methyllinderone
Catalog No.:BCN5452
CAS No.:3984-73-4
- 19-Hydroxybufalin
Catalog No.:BCN8237
CAS No.:39844-86-5
- JNJ 5207852 dihydrochloride
Catalog No.:BCC6101
CAS No.:398473-34-2
- PHA-680632
Catalog No.:BCC2178
CAS No.:398493-79-3
- H-D-Phe(4-OMe)-OH
Catalog No.:BCC2633
CAS No.:39878-65-4
- 29-Hydroxyfriedelan-3-one
Catalog No.:BCN5453
CAS No.:39903-21-4
- 2'-Deoxycytidine hydrochloride
Catalog No.:BCC5434
CAS No.:3992-42-5
- Norglaucine hydrochloride
Catalog No.:BCN6568
CAS No.:39945-41-0
- LY 78335
Catalog No.:BCC6109
CAS No.:39959-66-5
- Victoxinine
Catalog No.:BCN6745
CAS No.:39965-06-5
- HOAt
Catalog No.:BCC2815
CAS No.:39968-33-7
- Delta-9-Tetrahydrocannabivarinic acid
Catalog No.:BCN7967
CAS No.:39986-26-0
The effects of antibiotic type and extender storage method on sperm quality and antibacterial effectiveness in fresh and cooled-stored stallion semen.[Pubmed:30219312]
Theriogenology. 2018 Dec;122:23-29.
Two experiments were conducted to evaluate the effects of antibiotic-containing extender of on sperm quality and control of bacterial growth. In Experiment 1, ejaculates were diluted in extender containing no antibiotics, potassium penicillin G-Amikacin disulfate (PEN-AMIK), ticarcillin disodium-potassium clavulanate (TICAR-CLAV), piperacillin sodium/tazobactam sodium (PIP-TAZ), or meropenem (MERO). In freshly extended semen, only slight differences were detected among some antibiotic treatments for total sperm motility, curvilinear velocity, and viable acrosome-intact sperm (P<0.05). In cool-stored semen, slight differences were also detected among certain antibiotic treatments for curvilinear velocity and chromatin integrity (P<0.05). In Experiment 2, ejaculates were diluted in extender and subjected to no bacterial spiking, or inoculated with lower or higher doses of K. pneumoniae or P. aeruginosa. Following cooled storage of semen, colony forming units/ml (CFU/mL) were less in PEN-AMIK (706+/-244) and MERO (1576+/-1076) treatment groups than in TICAR-CLAV (4678+/-1388) or PIP-TAZ (8108+/-3198) treatment groups (P<0.05). The CFU/mL were lower in all antibiotic-containing treatment groups than the control group (18478+/-4374; P<0.05). The percentage of culture plates containing no bacterial growth in unspiked semen was greater in PEN-AMIK (75%) than PIP-TAZ (15%) or TICAR-CLAV (20%; P<0.05). The percentages of culture plates containing no bacterial growth in semen spiked with a lower doses of K. pneumoniae or P. aeruginosa were higher in PEN-AMIK (70% and 50%, respectively) then in all other treatment groups (0-40% and 0-15% for K. pneumonia and P. aeruginosa, respectively; P<0.05); however, complete control of bacterial load was only modest even with PEN-AMIK. In both experiments, freezing and thawing extender prior to use did not have any appreciable detrimental effect on sperm quality or antibiotic efficacy. In summary, all antibiotics tested had minimal effects on measures of sperm quality in fresh or cool-stored semen extenders; however, PEN-AMIK, followed by MERO, yielded the best results in terms of antimicrobial efficacy. None of the antibiotic types controlled bacterial growth, in comparison with the antibiotic-free control group, when extended semen was spiked with a high concentration of Pseudomonas aeruginosa. Cooled storage of extended semen reduced bacterial growth in comparison with freshly extended semen.
